Tangjitgamol S, Hanprasertpong J, Cubelli M, Zamagni C. Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 153-166 [DOI: 10.5317/wjog.v2.i4.153]
Corresponding Author of This Article
Siriwan Tangjitgamol, MD, Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, University of Bangkok Metropolis, 681 Samsen Road, Dusit, Bangkok 10300, Thailand. siriwanonco@yahoo.com
Research Domain of This Article
Obstetrics & Gynecology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Laparoscopic parameters assigned a predictive index score
Predictive index parameter
Point value
Sensitivity
Specificity
PPV
NPV
Accuracy
Omental cake
0
72.7%
68.3%
55.8%
82.0%
69.9%
Diaphragmatic carcinosis
0
77.1%
71.2%
61.4%
84.0%
73.4%
Mesenteral retraction
2
64.3%
98.2%
94.7%
85.0%
87.2%
Bowel infiltration
2
69.7%
86.0%
74.2%
84.1%
80.8%
Stomach infiltration
2
17.6%
100%
100%
67.4%
69.6%
Superficial liver metastasis
2
22.8%
100%
100%
68.9%
71.6%
Citation: Tangjitgamol S, Hanprasertpong J, Cubelli M, Zamagni C. Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 153-166